Hossein Eslami, CEO of Arman Pirouz Iranian Company (Apira Pharma), explained to Fana reporter on the sidelines of the opening ceremony of this factory: Apira Pharma, with three production lines for producing various semi-finished products, is one of the few companies that independently, separately and specializedly produces various types of pellets and DC granules with high standards equal to international standards. With an annual production capacity of 400 to 500 tons, Apira Pharma can supply an important part of the needs of pharmaceutical companies. We also hope to export to countries in the region, Asian countries and even European countries. In order to complete the value chain, we will receive a major part of the required raw materials from our group companies (Kimiya Group) and we will also sell our manufactured product to the pharmaceutical company of the Kimiya Group. This chain will create appropriate added value in the Kimiya Group.
